🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Eliem Therapeutics, Inc.

Eliem Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

ETX-810, ETX-155, Kv7 Program, Anxiolytic

Eliem Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for neuronal excitability disorders, including chronic pain and neuropsychiatry. Key products include ETX-810 in Phase IIa for chronic pain, and ETX-155 in Phase I for major depressive disorder.

Tags: biotechnology, chronic pain, clinical trials, drug development, epilepsy, neuronal excitability, neuropsychiatry

Symbol: ELYM

Recent Price: $5.11

Industry: Biotechnology

CEO: Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

Sector: Healthcare

Employees: 9

Address: 23515 NE Novelty Hill Road, Redmond, WA 98053

Phone: 425 276 2300

Last updated: 2024-12-31